| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","as_of":"2026-04-15T02:18:53.247056+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","article_chars":2058,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_e38e9f922ed3bc0a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","content_type":"text/plain","enriched_at":"2026-04-15T05:15:12.890282+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt","source_event_id":"evt_e3ccea1acaa3","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"72281345024990a7","kind":"sec_filing","published_at":"20260414","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-14","2026-04-15","2026-02-20","2026-04-08","2026-04-09","2026-04-14","2026-02-12","2026-02-23","2026-05-08","2026-04-08","2026-04-14"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"broker_or_agent"},{"asset_class":"equity","name":"EARGO, INC.","relevance":"low","symbol":"","type":"address_context"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only the new Form 144 filing content is shown.","The text does not explicitly state whether the listed quantities represent sales, dispositions, or other transfers beyond the Form 144 context.","No explicit total aggregate shares/dollars across all entries is clearly summarized in the provided text; only individual line items are visible.","No explicit security ticker symbol is provided in the extracted text (only 'NASDAQ Common' is shown)."],"key_facts":["SEC accession number: 0001959173-26-002899.","Form type: 144 (Form 144).","Filed as of date: 2026-04-14; date as of change: 2026-04-14.","Subject company/issuer: Twist Bioscience Corp (CIK: 0001581280; SEC file number: 001-38720).","Reporting owner: Adam Laponis (CIK: 0001827198).","Filing includes transactions for NASDAQ common stock (as indicated in the text).","The filing references an ESPP purchase dated 02/20/2026 (cash common; issuer N).","The filing references restricted stock vesting transactions dated 02/20/2026, 04/08/2026, and 04/14/2026 (issuer N; compensation/restricted stock vesting indicated).","The filing includes additional common stock entries with quantities and prices (e.g., 7000 shares at 350000.00; 2085 shares at 97389.93; 2597 shares at 129561.48), with dates shown in the text."],"numeric_claims":[{"label":"Total shares shown (example entries)","value":"7000; 2085; 2597 (multiple entries shown in text)"},{"label":"Total dollar amounts shown (example entries)","value":"350000.00; 97389.93; 129561.48 (multiple entries shown in text)"},{"label":"One listed price/amount field","value":"165000.00 (appears in the text near 04/14/2026)"}],"primary_claim":"On 2026-04-14, Twist Bioscience Corp filed SEC Form 144 (accession 0001959173-26-002899) reporting common stock transactions by Adam Laponis.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Twist Bioscience Corp filed a Form 144 on 2026-04-14. The filing relates to reported sales/dispositions of common stock by reporting owner Adam Laponis, including transactions tied to ESPP purchase and restricted stock vesting.","topics":["SEC Form 144","insider/affiliate sale/disposition","common stock","ESPP","restricted stock vesting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260414","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 144","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002899.txt"}... |